Cargando...
The Multifunction Of miR-218-5p-Cx43 Axis In Breast Cancer
BACKGROUND: Gemcitabine is proven to be the first-line standard treatment of breast cancers. Yet, little is known involving gemcitabine resistance and remains largely to be elucidated. MATERIALS AND METHODS: We evaluated the expression of Cx43 in gemcitabine-resistant cells and parental cells by qua...
Guardado en:
| Publicado en: | Onco Targets Ther |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790128/ https://ncbi.nlm.nih.gov/pubmed/31632081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S218524 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|